Leave Your Message

Tablet Friability Tester

Tablet Friability Tester A precision instrument that measures the resistance of uncoated tablets to chipping, abrasion, and breakage during handling. It rotates a sample of tablets in a drum, then calculates weight loss after tumbling.

Essential for quality control in pharmaceutical manufacturing to ensure tablets meet friability standards (e.g., USP <1216>, Ph. Eur. 2.9.7).

    Tablet Friability Tester: Instrument Overview

    The Tablet Friability Tester is a critical quality control instrument designed to evaluate the physical durability of uncoated tablets, granules, or pellets under simulated handling conditions. Following standardized pharmacopeial methodologies (including USP General Chapter <1216>, Ph. Eur 2.9.7, and IP), the instrument subjects a precisely weighed tablet sample to controlled tumbling within a rotating drum of specified dimensions.

    During testing, tablets undergo abrasion and impact forces through repeated falls over a predefined number of rotations (typically 100 cycles at 25 RPM). Post-test, the sample is reweighed, and friability is calculated as the percentage weight loss relative to the initial mass. A result ≤1.0% is generally considered acceptable for most solid dosage forms.

    Key features include a transparent polymethyl methacrylate (PMMA) drum, automated rotation counter, brushless motor for consistent speed, and integrated dust collection.

    Compliance with GMP/GLP requirements is ensured through calibration traceability, validation protocols, and audit trail capabilities.

    Technical Parameters:
    Product Model: CJY-300E
    Drum Dimensions:

    • Inner diameter: ≈286mm

    • Depth: 39mm
      Default Rotation Speed: 25 RPM
      Rotation Speed Range: 20–50 RPM
      Default Rotation Count: 100 cycles
      Rotation Count Range: 1–1000 cycles
      Rotation Direction: Clockwise/Counterclockwise
      Number of Drums: 2
      Power Supply: DC 12V 3A

    This instrument is indispensable for pharmaceutical manufacturers to verify tablet robustness, minimize production rejects, and comply with global regulatory standards.